HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

NATIXIS's Holding History (CIK: 0001274981)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 467,508 Value ($000) $31,463 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 125,572 Value ($000) $9,209 Avg Close $66.43 Range $51.78 - $79.50
Q1 2025
Shares 6,866 Value ($000) $435 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 207 Value ($000) $10 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 207 Value ($000) $12 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 194 Value ($000) $10 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 194 Value ($000) $8 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 158 Value ($000) $6 Avg Close $37.66 Range $32.83 - $42.82
Q3 2022
Shares 37,600 Value ($000) $1,487 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 67,900 Value ($000) $2,988 Avg Close $43.25 Range $36.95 - $48.58
Q4 2021
Shares 20,646 Value ($000) $830 Avg Close $37.33 Range $31.79 - $41.20
Q3 2021
Shares 50,636 Value ($000) $2,060 Avg Close $41.81 Range $37.80 - $46.62
Q2 2021
Shares 13,585 Value ($000) $617 Avg Close $44.26 Range $38.65 - $51.57
Q1 2021
Shares 36,585 Value ($000) $1,525 Avg Close $45.65 Range $38.80 - $56.40
Q4 2020
Shares 485,694 Value ($000) $20,744 Avg Close $35.95 Range $25.70 - $44.53